Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

Crane, Heidi M.; McCaul, Mary E.; Chander, Geetanjali; Hutton, Heidi E.; Nance, Robin M.; Delaney, Joseph A.; Merrill, Joseph O.; Lau, Bryan; Mayer, Kenneth H.; Mugavero, Michael J.; Mimiaga, Matthew J.; Willig, James H.; Burkholder, Greer A.; Drozd, Daniel R.; Fredericksen, Rob J.; Cropsey, Karen L.; Moore, Richard D.; Simoni, Jane M.; Mathews, W. Christopher; Eron, Joseph J.; Napravnik, Sonia; Christopoulos, Katerina; Geng, Elvin; Saag, Michael S.; Kitahata, Mari M.

doi:10.1007/s10461-017-1740-7

Cited by 109 publications

(65 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, substantial disparities remain (Hall et al, 2013) since African-Americans and Hispanics are at greater risk for HIV infection (Giordano et al, 2010; Harrison, Song, & Zhang, 2010; Siddiqi et al, 2015), and for failure to achieve viral suppression once infected (Castel et al, 2016; Xia, Sun, Wiewel, & Torian, 2017). HIV-infected individuals with alcohol and drug problems are also more likely than others to have poor health behaviors (Crane et al, 2017; Metrik, Caswell, Magill, Monti, & Kahler, 2016; Young, Wood, Dong, Kerr, & Hayashi, 2015), lower engagement in and utilization of HIV care, and lower ART adherence (Gwadz et al, 2016; Lake et al, 2017; Lucas, 2011). Further, the dual use of illicit drugs and alcohol, more than the use of either one alone, is associated with poor quality of HIV care (Dickson-Gomez, Bodnar, Petroll, Johnson, & Glasman, 2015; Korthuis et al, 2012), viral resistance to treatment, and HIV disease progression (Azar et al, 2015; Baum et al, 2009; Lima et al, 2014).…”

Section: Introductionmentioning

confidence: 99%

HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial

Aharonovich

Stohl

Cannizzaro

et al. 2017

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Aims Co-occurrence of drug and alcohol use among people living with HIV is linked to poor medication adherence and lack of viral suppression. HealthCall, a technological enhancement of brief Motivational Interviewing (MI), involves brief daily self-monitoring, positive reinforcement, and personalized feedback. This randomized pilot study among people living with HIV investigated the feasibility and efficacy of reducing non-injection drug and alcohol use with MI + HealthCall as adapted for smartphone technology. Design An urban, largely-minority community sample of adults living with HIV were screened for eligibility: last 30 day use of non-injection drugs (≥4 days of crack/cocaine, methamphetamine, or heroin use) and binge drinking (≥1 day of 4+ standard drinks). Those eligible were randomized to one of two groups: MI-only (n = 21) and MI + HealthCall-S (n = 21). Trained counselors delivered the brief MI at baseline. Drug and alcohol use assessments were completed at baseline, 30 and 60 days (end of treatment). Primary outcomes derived from a Timeline Follow Back (TLFB) of the past 30 days included (1) total number of days used primary drug (NumDU) (2) total quantity of primary drug used (dollar amount spent per day; QuantU), (3) total number of drinking days (NumDD) and (4) mean number of drinks per day (QuantDD). Feasibility was determined by HealthCall use rates, patient satisfaction questionnaire (1–5 scale, 5 being best), and retention. Findings The median daily use rate for HealthCall was 95%, patient satisfaction was excellent (4.5) and retention was high (93%). Both treatment groups reduced drug and alcohol use by end of treatment, with MI+Healthcall-S showing significantly greater reductions than MI-only in QuantU (p=0.01) and NumDU (p=0.046). P-values for reductions in alcohol quantity and frequency in the MI+Healthcall group were 0.09–0.11. Conclusions This proof-of-concept randomized trial indicates that HealthCall on the smartphone is a highly feasible intervention in urban, minority individuals with HIV, and suggests efficacy in reducing co-occurring drug and alcohol use. Results suggest opportunities for brief behavioral intervention that may be enhanced through interactive mobile technology to address complex alcohol and drug use patterns that interfere with HIV care, medication adherence and ultimately, viral suppression. A larger randomized trial is warranted to replicate and extend present results.

show abstract

Section: Introductionmentioning

confidence: 99%

HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial

Aharonovich

Stohl

Cannizzaro

et al. 2017

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

show abstract

“…Recent reports suggest that marijuana use is even more widespread among PWH [7–8]. A multicenter cohort of HIV infected patients receiving care in 8 US cities between 2013–2015 found 31.6% of patients reported marijuana use during the past 3 months [9]. In a recent Florida sample of PWH in care, 20% reported recent marijuana use with 7% reporting daily use [10].…”

Section: Introductionmentioning

confidence: 99%

Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic

Sinha

McCaul

Hutton

et al. 2017

Journal of Substance Abuse Treatment

Self Cite

View full text Add to dashboard Cite

Background While marijuana use is prevalent among persons with HIV (PWH), few studies have examined the relationship between marijuana use and HIV treatment outcomes independent of alcohol and other drug use. Methods We conducted a prospective cohort study to examine the relationships between frequency of marijuana use and antiretroviral therapy (ART) adherence and viral suppression in patients enrolled in the Johns Hopkins HIV Clinical Cohort between September 2013 through November 2015 (N=1377). We categorized marijuana use as no use, none in the last 3 months, monthly use or less, weekly/daily. Our outcomes of interest were use of ART, ≥90 ART adherence, and viral suppression (HIV1-RNA <200 copies). We conducted multivariable analyses to examine associations between the frequency of marijuana use and our treatment outcomes, using generalized estimating equations to account for repeated measures. Other independent variables of interest included alcohol use, other drug use, and depressive symptoms. Analyses were adjusted for age, race, sex and HIV acquisition risk factor. Results In multivariable analyses we found no statistically significant association between frequency of marijuana use and our treatment outcomes. Alcohol use, other drug use and depressive symptoms were associated with lower odds of ART adherence and viral suppression. Conclusions In this sample of PWH in care, frequency of marijuana use independent of other substance use does not appear to be associated with negative HIV treatment outcomes. Our results indicate that unlike alcohol, other substances and depression, marijuana use may not be a barrier to the effective treatment of HIV.

show abstract

“…[12][13][14] In developed countries, factors associated with increased risk of hazardous alcohol consumption included substance use (cocaine or marijuana, for example) and working in cities with a higher marginalisation index. 15,16 Within the past 2 decades, road traffic accidents in Africa have escalated from 40.7 to 92.9 per 100,000, and yet alcohol consumption remains the main contributing factor. [17][18][19] To our knowledge, there is limited information on the magnitude of hazardous alcohol consumption among motorcycle taxi riders provided that 21.7% of all road traffic accidents in Tanzania are suspected to be under the influence of alcohol and 53.4% of all road traffic accidents involved motorcycles.…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Factors Associated With Hazardous Alcohol Consumption Among Motorcycle Taxi Riders in Kinondoni District, Dar-Es-Salaam, Tanzania: A Cross-Sectional Study

Kitua

Kabalimu

Muindi

2019

EAHRJ

View full text Add to dashboard Cite

Background: Hazardous alcohol consumption is a significant public health problem contributing to road traffic accidents in nearly all countries. Despite the fact that motorcycles are involved in more than half of all road traffic accidents in Tanzania, little has been reported about hazardous alcohol consumption among motorcyclists. This study investigated the prevalence and factors associated with hazardous alcohol consumption among motorcycle taxi riders in Kinondoni District, Dar es Salaam. Methods: A cross-sectional survey was conducted in Kinondoni District in August 2018 among motorcycle taxi riders. Multistage sampling was applied to select the study participants. Data were collected using structured self-administered questionnaires incorporating the Alcohol Use Disorders Identification Test. Analysis was done using IBM SPSS version 20. Results: A total of 210 individuals participated in the study. Within the study sample, the prevalence of hazardous alcohol consumption was 61.5% (n=128). Hazardous alcohol consumption was positively associated with a positive family history of alcohol consumption (odds ratio [OR] 11.74; 95% confidence interval [CI], 5.14 to 26.79; P<.001). Protective factors were younger age (OR 0.09; 95% CI, 0.02 to 0.40; P<.001), having a secondary level of education (OR 0.21; 95% CI, 0.04 to 0.99; P=.034), having a primary level of education (OR 0.06; 95% CI, 0.01 to 0.26; P<.001), and being employed (OR 11.74; 95% CI, 5.14 to 26.79; P<.001). Conclusion: A high prevalence of hazardous alcohol consumption among motorcycle taxi riders was reported along with several associated factors. Interventions to mitigate hazardous alcohol consumption among commercial motor vehicle drivers must be developed and implemented.

show abstract

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

Cited by 109 publications

References 53 publications

HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial

HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial

Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic

Prevalence and Factors Associated With Hazardous Alcohol Consumption Among Motorcycle Taxi Riders in Kinondoni District, Dar-Es-Salaam, Tanzania: A Cross-Sectional Study

Contact Info

Product

Resources

About